Summary of HR 5768: Skin Substitute Access and Payment Reform Act

Purpose and Intent

The Skin Substitute Access and Payment Reform Act (HR 5768) aims to improve access to skin substitutes for patients requiring advanced wound care. The bill seeks to reform the payment structures associated with these medical products, ensuring that healthcare providers can offer necessary treatments without financial barriers.

Key Provisions

The bill includes several significant provisions designed to enhance the accessibility and affordability of skin substitutes:

• Payment Reform: HR 5768 proposes changes to the reimbursement models for skin substitutes under Medicare and Medicaid. This includes:

  • Establishing a new payment framework that reflects the actual costs of skin substitutes.
  • Ensuring timely reimbursement to healthcare providers to encourage the use of these products in patient care.

• Access Improvement: The legislation aims to streamline the approval process for new skin substitute products, facilitating quicker access for patients in need.

• Patient Education: The bill emphasizes the importance of educating patients and healthcare providers about the availability and benefits of skin substitutes, promoting informed decision-making in treatment options.

Who Would Be Affected

The following groups would be directly impacted by the provisions of HR 5768:

• Patients: Individuals suffering from chronic wounds, burns, or other skin-related conditions would benefit from improved access to advanced treatment options.

• Healthcare Providers: Hospitals, clinics, and practitioners involved in wound care would experience changes in reimbursement processes, potentially leading to increased utilization of skin substitutes.

• Manufacturers: Companies producing skin substitutes may see changes in market dynamics due to streamlined approval processes and new reimbursement models.

Procedural Aspects

• Introduced Date: The bill was introduced in the House on October 17, 2025.

• Committee Review: Upon introduction, HR 5768 was referred to the Committee on Energy and Commerce and the Committee on Ways and Means. The Speaker will determine the period for consideration of the bill by these committees.

Conclusion

The Skin Substitute Access and Payment Reform Act (HR 5768) represents a significant step towards enhancing patient care in wound management by reforming payment structures and improving access to essential medical products. As the bill progresses through the legislative process, it has the potential to positively impact patients, healthcare providers, and manufacturers in the field of advanced wound care.